EndoStim announced on October 25th that the FDA granted a breakthrough device designation for the company’s implantable neurostimulation treatment for drug refractory gastroesophageal reflux disease...
The article provides an overview of the applicable regulatory requirements for ethical considerations in the context of clinical investigations of medical devices initially intended...
BOCA RATON, Fla., Oct. 27, 2022 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive treatments...
TEL AVIV, Israel--(BUSINESS WIRE)-- Radiaction Medical, Ltd. (“Radiaction”), a medical device innovator dedicated to providing healthcare physicians and staff with effective radiation protection during...
The electronic registration certificate for medical devices will be fully implemented, from November 1, 2022.
After October 2020, when the electronic certificates for domestic class...
L-Dex Found to be a Cost Effective, Reproducible, and Practical Method to Monitor Breast Cancer Patients for Early Signs of Lymphedema
CARLSBAD, Calif., Oct. 26,...
